Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow-to-Debt Ratio
Henan Taloph Pharmaceutical Stock Co Ltd cash flow-to-debt ratio. Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥22.69 Million could theoretically repay 0% of its total liabilities (CN¥2.09 Billion) in one year. Check cash flow quality index of Henan Taloph Pharmaceutical Stock Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Cash flow-to-debt ratio of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. Historical debt coverage capacity for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. Check Henan Taloph Pharmaceutical Stock Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Henan Taloph Pharmaceutical Stock Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Henan Taloph Pharmaceutical Stock Co Ltd. For the full cash flow conversion analysis, see 600222 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥47.16 Million | CN¥1.98 Billion | ▲ +212.2% |
| 2024 | -0.02x | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -194.9% |
| 2023 | 0.02x | CN¥43.74 Million | CN¥1.95 Billion | ▲ +135.7% |
| 2022 | -0.06x | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -226.1% |
| 2021 | 0.05x | CN¥99.66 Million | CN¥2.01 Billion | ▲ +25.8% |
| 2020 | 0.04x | CN¥73.43 Million | CN¥1.86 Billion | ▲ +35.8% |
| 2019 | 0.03x | CN¥41.53 Million | CN¥1.43 Billion | ▼ -64.8% |
| 2018 | 0.08x | CN¥119.47 Million | CN¥1.44 Billion | ▲ +364.2% |
| 2017 | 0.02x | CN¥23.17 Million | CN¥1.30 Billion | ▼ -70.9% |
| 2016 | 0.06x | CN¥70.60 Million | CN¥1.15 Billion | ▲ +42.0% |
| 2015 | 0.04x | CN¥49.27 Million | CN¥1.14 Billion | ▼ -46.6% |
| 2014 | 0.08x | CN¥89.54 Million | CN¥1.11 Billion | ▲ +1149.2% |
| 2013 | -0.01x | CN¥-6.65 Million | CN¥861.22 Million | ▼ -108.1% |
| 2012 | 0.10x | CN¥87.45 Million | CN¥912.93 Million | ▲ +75588.3% |
| 2011 | 0.00x | CN¥105.20K | CN¥831.28 Million | ▲ +100.4% |
| 2010 | -0.03x | CN¥-20.00 Million | CN¥641.92 Million | ▼ -173.6% |
| 2009 | 0.04x | CN¥21.45 Million | CN¥506.12 Million | ▼ -10.9% |
| 2008 | 0.05x | CN¥18.13 Million | CN¥381.43 Million | ▼ -28.0% |
| 2007 | 0.07x | CN¥21.34 Million | CN¥323.29 Million | ▲ +1234.1% |
| 2006 | 0.00x | CN¥1.59 Million | CN¥322.24 Million | ▲ +398.9% |
| 2005 | 0.00x | CN¥276.30K | CN¥278.70 Million | ▼ -98.5% |
| 2004 | 0.06x | CN¥18.25 Million | CN¥283.44 Million | ▲ +362.1% |
| 2003 | 0.01x | CN¥3.74 Million | CN¥268.36 Million | ▼ -50.6% |
| 2002 | 0.03x | CN¥7.47 Million | CN¥264.70 Million | ▼ -89.4% |
| 2001 | 0.27x | CN¥55.03 Million | CN¥206.07 Million | ▲ +4855.7% |
| 2000 | 0.01x | CN¥875.36K | CN¥162.45 Million | ▼ -99.2% |
| 1999 | 0.66x | CN¥99.32 Million | CN¥151.10 Million | ▲ +286.3% |
| 1998 | 0.17x | CN¥28.04 Million | CN¥164.79 Million | — |